MedPath
HSA Approval

BEAKOPECTIN SUSPENSION

SIN06076P

BEAKOPECTIN SUSPENSION

BEAKOPECTIN SUSPENSION

May 23, 1991

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

A07BC30

combinations

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

PECTIN

130mg/30ml

Pectin

KAOLIN COLLOIDAL

6000mg/30ml

Kaolin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEAKOPECTIN SUSPENSION - HSA Approval | MedPath